2-26519015-T-C
Variant summary
Our verdict is Likely benign. The variant received -3 ACMG points: 0P and 3B. BP4_ModerateBP6
The NM_194248.3(OTOF):c.322A>G(p.Ile108Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000579 in 1,606,180 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_194248.3 missense
Scores
Clinical Significance
Conservation
Publications
- autosomal recessive nonsyndromic hearing loss 9Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P
- hearing loss, autosomal recessiveInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -3 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000722 AC: 11AN: 152252Hom.: 0 Cov.: 34 show subpopulations
GnomAD2 exomes AF: 0.000108 AC: 26AN: 241140 AF XY: 0.000169 show subpopulations
GnomAD4 exome AF: 0.0000564 AC: 82AN: 1453810Hom.: 1 Cov.: 30 AF XY: 0.0000830 AC XY: 60AN XY: 722680 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000722 AC: 11AN: 152370Hom.: 0 Cov.: 34 AF XY: 0.000107 AC XY: 8AN XY: 74510 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1
The Ile108Val variant in OTOF has not been previously reported in individuals wi th hearing loss and was absent from large population studies. Computational pred iction tools and conservation analysis do not provide strong support for or agai nst an impact to the protein. In summary, the clinical significance of the Ile10 8Val variant is uncertain. -
Inborn genetic diseases Uncertain:1
The c.322A>G (p.I108V) alteration is located in exon 4 (coding exon 4) of the OTOF gene. This alteration results from a A to G substitution at nucleotide position 322, causing the isoleucine (I) at amino acid position 108 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at